Suppr超能文献

黄酮类衍生物靶向 BCR-ABL 激酶:半合成、分子动力学模拟和酶抑制。

Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition.

机构信息

Programa de Pos-Graduacao em Agroquimica, Universidade Federal do Espirito Santo, 29500000, Alegre - ES, Brazil.

Programa de Pos-Graduacao em Quimica, Universidade Federal do Espirito Santo, 29075910, Vitoria- ES, Brazil.

出版信息

Curr Top Med Chem. 2021;21(22):1999-2017. doi: 10.2174/1568026621666210705170047.

Abstract

BACKGROUND

Natural products have been universally approached in the research of novel trends useful to detail the essential paths of the life sciences and as a strategy for pharmacotherapeutics.

OBJECTIVE

This work focuses on further modification to the 6-hydroxy-flavanone building block aiming to obtain improved BCR-ABL kinase inhibitors.

METHODS

Ether derivatives were obtained from Williamson synthesis and triazole from Microwave- assisted click reaction. Chemical structures were finely characterized through IR, 1H and 13C NMR and HRMS. They were tested for their inhibitory activity against BCR-ABL kinase.

RESULTS

Two inhibitors bearing a triazole ring as a pharmacophoric bridge demonstrated the strongest kinase inhibition at IC50 value of 364 nM (compound 3j) and 275 nM (compound 3k).

CONCLUSION

6-hydroxy-flavanone skeleton can be considered as a promising core for BCR-ABL kinase inhibitors.

摘要

背景

天然产物一直是新趋势研究的热点,有助于深入了解生命科学的基本途径,并可作为药物治疗的策略。

目的

本工作专注于对 6-羟基黄酮母核进行进一步修饰,以获得改进的 BCR-ABL 激酶抑制剂。

方法

通过Williamson 合成得到醚衍生物,通过微波辅助点击反应得到三唑。通过 IR、1H 和 13C NMR 以及高分辨率质谱对化学结构进行了精细表征。测试了它们对 BCR-ABL 激酶的抑制活性。

结果

两个含有三唑环作为药效团桥的抑制剂在 IC50 值为 364 nM(化合物 3j)和 275 nM(化合物 3k)时表现出最强的激酶抑制作用。

结论

6-羟基黄酮骨架可被视为 BCR-ABL 激酶抑制剂的有前途的核心。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验